First Opinion Podcast Patrick Skerrett Listen: Why is eugenics still alive and well in scientific publishing?
Health tech Timmy Broderick STAT Plus: Novel amputation procedure makes walking with a prosthetic leg feel more seamless
Health Isabella Cueto STAT Plus: Medicare’s big experiment to fix kidney failure care hasn’t worked so far, studies say
The Readout Meghana Keshavan STAT Plus: Will Medicare finally begin covering weight loss drugs like Zepbound and Wegovy?
In the Lab Jason Mast STAT Plus: Trying to outrun her prion disease, researcher creates powerful epigenetic editor in mice
In the Lab Angus Chen STAT Plus: Journal retracts study tied to Micronoma’s effort to create cancer blood test
Pharmalot Ed Silverman STAT Plus: U.K. pharma increasingly violates voluntary industry marketing codes, and probes are taking longer
First Opinion Andrew D. Forsyth, Mallory O. Johnson, and Jae M. Sevelius Turning a ‘no’ vote into progress: How to advance MDMA-assisted psychotherapy for PTSD
Pharmalot Ed Silverman STAT Plus: Pharmalittle: We’re reading about FDA approval for Sarepta drug, MSF closing access campaign and more
In the Lab Angus Chen STAT Plus: New immunotherapy combination could ‘change the landscape’ of cancer treatment
In the Lab Usha Lee McFarling Coalition wages campaign for retractions of Richard Lynn’s racist journal articles
Pharmalot Ed Silverman STAT Plus: Pharmalittle: We’re reading about Lilly lawsuits, Novo Nordisk fires and much more
First Opinion Dan Samorodnitsky, Kevin Bird, Jedidiah Carlson, James Lingford, Jon Phillips, Rebecca Sear, and Cathryn Townsend Journals that published Richard Lynn’s racist ‘research’ articles should retract them
Health Jonathan Wosen STAT Plus: New study bolsters evidence rare genetic mutation can delay early Alzheimer’s
Politics Sarah Owermohle STAT Plus: With sweeping NIH reform on the table, GOP previews new era of research scrutiny
Health Nicholas Florko Vaping is just as good as Chantix at helping people quit cigarettes, new study finds
Pharmalot Ed Silverman STAT Plus: Pharmalittle: We’re reading about abortion pill access, employer coverage of GLP-1 drugs and more